Cargando…

Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity

BACKGROUND: Multidrug-resistant (MDR) tuberculosis has low treatment success rates, and new treatment strategies are needed. We explored whether treatment with active vitamin D(3) (vitD) and phenylbutyrate (PBA) could improve conventional chemotherapy by enhancing immune-mediated eradication of Myco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao Muvva, Jagadeeswara, Ahmed, Sultan, Rekha, Rokeya Sultana, Kalsum, Sadaf, Groenheit, Ramona, Schön, Thomas, Agerberth, Birgitta, Bergman, Peter, Brighenti, Susanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280489/ https://www.ncbi.nlm.nih.gov/pubmed/33606878 http://dx.doi.org/10.1093/infdis/jiab100

Ejemplares similares

Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation
por: Ahmed, Sultan, et al.
Publicado: (2020)

Host Directed Therapy Against Infection by Boosting Innate Immunity
por: Bergman, Peter, et al.
Publicado: (2020)

Polarization of Human Monocyte-Derived Cells With Vitamin D Promotes Control of Mycobacterium tuberculosis Infection
por: Rao Muvva, Jagadeeswara, et al.
Publicado: (2020)

Impaired Release of Antimicrobial Peptides into Nasal Fluid of Hyper-IgE and CVID Patients
por: Cederlund, Andreas, et al.
Publicado: (2011)

Phenylbutyrate Counteracts Shigella Mediated Downregulation of Cathelicidin in Rabbit Lung and Intestinal Epithelia: A Potential Therapeutic Strategy
por: Sarker, Protim, et al.
Publicado: (2011)

Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial
por: Mily, Akhirunnesa, et al.
Publicado: (2015)

Vitamin D(3) supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study
por: Bergman, Peter, et al.
Publicado: (2012)

Crossroads of Antimicrobial and Diagnostic Stewardship: Assessing Risks to Develop Clinical Decision Support to Combat Multidrug-Resistant Pseudomonas
por: Zou, Iris, et al.
Publicado: (2023)

Inhibition of Tissue Matrix Metalloproteinases Interferes with Mycobacterium tuberculosis-Induced Granuloma Formation and Reduces Bacterial Load in a Human Lung Tissue Model
por: Parasa, Venkata R., et al.
Publicado: (2017)

Differential Host Immune Responses to Epidemic and Endemic Strains of Shigella dysenteriae Type 1
por: Sayem, Mohammad Abu, et al.
Publicado: (2011)

Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D(3) as host directed therapy
por: Rekha, Rokeya Sultana, et al.
Publicado: (2018)

Oral intake of phenylbutyrate with or without vitamin D(3) upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis
por: Mily, Akhirunnesa, et al.
Publicado: (2013)

Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial
por: Raqib, Rubhana, et al.
Publicado: (2012)

Immunosuppressive Features of the Microenvironment in Lymph Nodes Granulomas from Tuberculosis and HIV–Co-Infected Patients
por: Ashenafi, Senait, et al.
Publicado: (2022)

Repurposing Immunomodulatory Drugs to Combat Tuberculosis
por: Fatima, Samreen, et al.
Publicado: (2021)

A high-throughput screening assay based on automated microscopy for monitoring antibiotic susceptibility of Mycobacterium tuberculosis phenotypes
por: Kalsum, Sadaf, et al.
Publicado: (2021)

Contact tracing as a measure to combat COVID-19 and other infectious diseases
por: Du, Marvin
Publicado: (2022)

Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes
por: Mily, Akhirunnesa, et al.
Publicado: (2020)

Novel aroylated phenylenediamine compounds enhance antimicrobial defense and maintain airway epithelial barrier integrity
por: Myszor, Iwona T., et al.
Publicado: (2019)

Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis
por: Mase, Anjeli, et al.
Publicado: (2022)

Resistance Patterns and Clinical Significance of Candida Colonization and Infection in Combat-Related Injured Patients From Iraq and Afghanistan
por: Blyth, Dana M., et al.
Publicado: (2014)

Targeted Nutrition in Chronic Disease
por: Bergman, Peter, et al.
Publicado: (2020)

Immunomodulatory nanosystems: An emerging strategy to combat viral infections
por: Khatun, Sajmina, et al.
Publicado: (2023)

The Impact of Multidrug-Resistant Organisms on Outcomes in Patients With Diabetic Foot Infections
por: Henig, Oryan, et al.
Publicado: (2020)

Model-Based Efficacy and Toxicity Comparisons of Moxifloxacin for Multidrug-Resistant Tuberculosis
por: Yun, Hwi-Yeol, et al.
Publicado: (2021)

Predicting Risk of Multidrug-Resistant Enterobacterales Infections Among People With HIV
por: Henderson, Heather I, et al.
Publicado: (2022)

Intra-abdominal Infections: The Role of Anaerobes, Enterococci, Fungi, and Multidrug-Resistant Organisms
por: Marcus, Gil, et al.
Publicado: (2016)

Ultraviolet-C Light Evaluation as Adjunct Disinfection to Remove Multidrug-Resistant Organisms
por: Rock, Clare, et al.
Publicado: (2021)

The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections
por: Shi, Jingru, et al.
Publicado: (2022)

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study
por: Gallagher, Jason C, et al.
Publicado: (2018)

Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

BCG-specific IgG-secreting peripheral plasmablasts as a potential biomarker of active tuberculosis in HIV negative and HIV positive patients
por: Ashenafi, Senait, et al.
Publicado: (2013)

Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis
por: Salindri, Argita D., et al.
Publicado: (2016)

Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry
por: Galli, Laura, et al.
Publicado: (2020)

Impact of Testing Strategies to Combat a Major Syphilis Outbreak Among Australian Aboriginal and Torres Strait Islander Peoples: A Mathematical Modeling Study
por: Hui, Ben B, et al.
Publicado: (2022)

Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical Centers
por: Sader, Helio S, et al.
Publicado: (2023)

Breaking the Spell: Combating Multidrug Resistant ‘Superbugs’
por: Khan, Shahper N., et al.
Publicado: (2016)

Combating multidrug‐resistant Plasmodium falciparum malaria
por: Thu, Aung Myint, et al.
Publicado: (2017)

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil
por: Polly, Matheus, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ofkb0och6gmbqidkvpmttb3cqs